Sensitization to Api m 1, Api m 2, and Api m 4: association with safety of bee venom immunotherapy.
Department of Allergology, Hospital General La Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain. Electronic address: rulebe@gmail.com.
Berta
B
Ruiz
Department of Allergology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Pilar
P
Serrano
Department of Allergology, Hospital Universitario de Ceuta, Ceuta, Spain.
Miriam
M
Verdú
Department of Allergology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Carmen
C
Moreno
D000328:Adult; D000485:Allergens / Q000276:immunology*; D000818:Animals; D001514:Bee Venoms / Q000627:therapeutic use*; D001516:Bees / Q000276:immunology; D015415:Biomarkers / Q000378:metabolism; D003888:Desensitization, Immunologic / Q000379:methods*; D018450:Disease Progression; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000276:immunology*; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007114:Immunization; D007073:Immunoglobulin E / Q000097:blood; D019476:Insect Proteins / Q000276:immunology*; D008297:Male; D008555:Melitten / Q000276:immunology*; D008875:Middle Aged; D010741:Phospholipases A / Q000276:immunology*; D055815:Young Adult
D000485:Allergens; D001514:Bee Venoms; D015415:Biomarkers; D019476:Insect Proteins; D008555:Melitten; D007073:Immunoglobulin E; D010741:Phospholipases A; C497838:Api m 1 allergen, Apis mellifera; C497839:Api m 2 allergen, Apis mellifera; D006821:Hyaluronoglucosaminidase